Overview
We are focused on developing and marketing branded and generic formulations. Our formulations business spans across various geographies primarily the US, India, Europe, Latin America and Rest of the World. We focus on manufacturing niche products across therapeutic areas of dermatology, respiratory and oncology. We have 14 manufacturing facilities
across India, the US, Argentina and Czech Republic. These facilities are inspected by various regulatory bodies, including the US-FDA, MHRA UK, SUKUL-CZ, RU-GMP Russia, TGA Australia, WHO GMP, TPD Canada, MCC South Africa and ANVISA Brazil. Being a research-driven organization, we have also invested in dedicated R&D centers for global markets.
Quality at Glenmark
At Glenmark, quality is of paramount importance and stringent checks go into every product we manufacture. Our principles of excellence and the emphasis to ensure a culture of uncompromising quality, has earned us a remarkable reputation with our customers and regulatory agencies around the globe. This is reflected in the multiple accolades and recognitions conferred on us over the years. We have 14 state-of-the-art manufacturing facilities that are
inspected by various regulatory bodies such as the US-FDA, MHRA UK, SUKUL-CZ, RU-GMP Russia, TGA Australia, WHO GMP, TPD Canada, MCC South Africa and ANVISA of Brazil. At Glenmark, we are relentless in stepping up our quality systems across our research and manufacturing facilities, ensuring that our products, processes and infrastructure – all measure up to international expectations.
Manufacturing Facilities Delivering high quality products across the globe
